KUMANOGOH; Atsushi
Patent Applications and Registrations
Patent applications and USPTO patent grants for KUMANOGOH; Atsushi.The latest application filed is for "anti-cd98hc antibody".
- KUMANOGOH; Atsushi - Osaka JP
- KUMANOGOH; Atsushi - Suita-shi JP
- Kumanogoh; Atsushi - Suita JP
- Kumanogoh; Atsushi - Ikeda Osaka JP
| Patent | Date |
|---|---|
| ANTI-CD98hc ANTIBODY App 20220064287 - HOSEN; Naoki ; et al. | 2022-03-03 |
| Antibody App 20220041735 - HOSEN; Naoki ; et al. | 2022-02-10 |
| Antibody Grant 10,988,540 - Hosen , et al. April 27, 2 | 2021-04-27 |
| Tumor Immunomodulator App 20210113594 - IWAHORI; Kota ; et al. | 2021-04-22 |
| Therapeutic Agent For Autoimmune Diseases Or Allergy, And Method For Screening For The Therapeutic Agent App 20210003571 - KUMANOGOH; Atsushi | 2021-01-07 |
| Antibody App 20200385474 - HOSEN; Naoki ; et al. | 2020-12-10 |
| Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent Grant 10,794,907 - Kumanogoh October 6, 2 | 2020-10-06 |
| Antibody App 20200283533 - HOSEN; Naoki ; et al. | 2020-09-10 |
| Antiplexin A1 Agonist Antibody App 20200276302 - Kumanogoh; Atsushi ; et al. | 2020-09-03 |
| Eye Disease Biomarker App 20200270686 - Nishida; Kohji ; et al. | 2020-08-27 |
| AntiPlexin A1 agonist antibody Grant 10,688,178 - Kumanogoh , et al. | 2020-06-23 |
| Antibody Grant 10,654,931 - Hosen , et al. | 2020-05-19 |
| Stress Biomarker App 20190119747 - Nishida; Kohji ; et al. | 2019-04-25 |
| Antibody App 20180230212 - HOSEN; Naoki ; et al. | 2018-08-16 |
| Antibody App 20180230216 - HOSEN; Naoki ; et al. | 2018-08-16 |
| Antiplexin A1 Agonist Antibody App 20180193451 - KUMANOGOH; Atsushi ; et al. | 2018-07-12 |
| Therapeutic Agent For Autoimmune Diseases Or Allergy, And Method For Screening For The Therapeutic Agent App 20140349311 - KUMANOGOH; Atsushi | 2014-11-27 |
| Therapeutic Agent For Autoimmune Diseases Or Allergy, And Method For Screening For The Therapeutic Agent App 20120322085 - Kumanogoh; Atsushi | 2012-12-20 |
| Costimulatory Molecules and Uses Thereof App 20080317766 - Kikutani; Hitoshi ; et al. | 2008-12-25 |
| Compositions for inhibiting Sema7A and VLA-1 interaction and the methods of using the same Grant 7,462,461 - Kikutani , et al. December 9, 2 | 2008-12-09 |
| Costimulatory Molecules and Uses thereof App 20080058257 - Kikutani; Hitoshi ; et al. | 2008-03-06 |
| Compositions for Inhibiting plexin-A1-DAP12 interactions and Methods of Treating Inflammatory, Autoimmune or Bone Resorption Diseases Using the Same App 20080045443 - KIKUTANI; Hitoshi ; et al. | 2008-02-21 |
| Compositions for Inhibiting Sema7A and VLA-1 Interaction and the Methods of Using the Same App 20070264263 - Kikutani; Hitoshi ; et al. | 2007-11-15 |
| Human Sema4a Protein Antibodies And Uses Thereof App 20070237773 - KIKUTANI; Hitoshi ; et al. | 2007-10-11 |
| Methods Of Identifying Compounds Capable Of Modulating T Cell Immune Responses Involving Sema4a Protein App 20070160604 - Kikutani; Hitoshi ; et al. | 2007-07-12 |
| Costimulatory molecules and uses thereof App 20040052782 - Kikutani, Hitoshi ; et al. | 2004-03-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 